How glycosylation aids tumor angiogenesis: An updated review

Biomed Pharmacother. 2018 Jul:103:1246-1252. doi: 10.1016/j.biopha.2018.04.119. Epub 2018 May 7.

Abstract

Glycosylation is an enzymatic process in which a carbohydrate is attached to a functional group from another molecule. Glycosylation is a crucial post translational process in protein modification. The tumor microenvironment produces altered glycans that contribute to cancer progression and aggressiveness. Abnormal glycosylation is widely observed in tumor angiogenesis. Despite many attempts to decipher the role of glycosylation in different aspects of cancer, little is known regarding the roles of glycans in angiogenesis. The blood vessels in tumors are often used to transport oxygen and nutrients for tumor progression and metastasis. The crosstalk within the tumor microenvironment can induce angiogenesis by manipulating these glycans to hijack the normal angiogenesis process, thus promoting tumor growth. Abnormal glycosylation has been shown to promote tumor angiogenesis by degrading the extracellular matrix to activate the angiogenic signaling pathways. This review highlights the latest update on how glycosylation can contribute to tumor angiogenesis that may affect treatment outcomes.

Keywords: Angiogenesis; Glycans; Glycosylation; Tumor.

Publication types

  • Review

MeSH terms

  • Animals
  • Glycosylation
  • Humans
  • Models, Biological
  • Neoplasms / blood supply*
  • Neoplasms / metabolism*
  • Neovascularization, Pathologic / metabolism*
  • Neovascularization, Pathologic / pathology